Citrate Buffer Solution 0.09 M

• Description:

  Citrate Buffer Solution 0.09 M_x000D_ Catalog number: B2016265_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: 2-8°C_x000D_ Keywords: Citrate Buffer Solution, 0.09 M_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid Hemodial Int. 2013 Apr;17(2):313-20._x000D_ 2: Li J, Chatterjee K, Medek A, Shalaev E, Zografi G. Acid-base characteristics of bromophenol blue-citrate buffer systems in the amorphous state J Pharm Sci. 2004 Mar;93(3):697-712._x000D_ 3: Islam MR. Can potassium citrate replace sodium bicarbonate and potassium chloride of oral rehydration solution? Arch Dis Child. 1985 Sep;60(9):852-5._x000D_ 4: Nurmohamed SA, Jallah BP, Vervloet MG, Yldirim G, ter Wee PM, Groeneveld AB. Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study BMC Nephrol. 2013 Apr 18;14:89._x000D_ 5: Richtrova P, Mares J, Kielberger L, Trefil L, Eiselt J, Reischig T. Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility Artif Organs. 2017 Aug;41(8):759-766._x000D_ 6: Gao F, Matsuya S, Ohta M, Zhang J. Erosion process of light-cured and conventional glass ionomer cements in citrate buffer solution Dent Mater J. 1997 Dec;16(2):170-9._x000D_ 7: Lew SQ, Kohn OF, Cheng YL, Kjellstrand CM, Ing TS. Three-Stream, Bicarbonate-Based Hemodialysis Solution Delivery System Revisited: With an Emphasis on Some Aspects of Acid-Base Principles Artif Organs. 2017 Jun;41(6):509-518._x000D_ 8: Mandolfo S, Borlandelli S, Elli A. Catheter lock solutions: it's time for a change J Vasc Access. 2006 Jul-Sep;7(3):99-102._x000D_ 9: Abdel Azim ABE, ElSaid TW, El Said HW, Hemida W, Zaghlool S, Ramadan A, Gouda Z, El Masry S, Reda W, Ali HM. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients€© Clin Nephrol. 2018 Nov;90(5):341-349._x000D_ 10: Bodega-Azuara J, Bellés-Medall MD, Edo-Peñarrocha J, Ferrando-Piqueres R, Perez-Alba A, Reque-Santivañez J. Vancomycin and daptomycin stability in heparin or sodium citrate lock solutions J Vasc Access. 2023 Jul;24(4):696-701. _x000D_ _x000D_ Products Related to Citrate Buffer Solution 0.09 M can be found at Chemicals

• Short Description:

  Catalog Number: B2016265 (50 mL)_x000D_ Citrate Buffer Solution 0.09 M is a high quality Citrate Buffer Solution 0.09 M. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  2.6

• Length:

  3.3

• Width:

  1.2

• Height :

  1.2